Home » Topics » Conferences

Conferences
RSS

Riluzole exhibits cardioprotective activity in vivo

Aug. 17, 2010

FT-23 attenuates diastolic dysfunction in model of diabetic cardiomyopathy

Aug. 16, 2010

Iontophoretically delivered terbinafine enters phase II trial in onychomycosis

Aug. 16, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

Onabotulinumtoxin A is safe and efficacious in women with vertical lip columns

Aug. 13, 2010

New clindamycin/tretinoin gel more effective than constituents in treating acne

Aug. 13, 2010

Cannabinoids show promise in models of inflammation and bone loss

Aug. 13, 2010

Abobotulinumtoxin A rapidly reduces glabellar lines in phase III trials

Aug. 13, 2010

Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis

Aug. 13, 2010

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Aug. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.